Detalhe da pesquisa
1.
Paroxysmal nocturnal hemoglobinuria-related thrombosis in the era of novel therapies: a 2043 patient/years analysis.
Blood
; 2024 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38513233
2.
Circular RNAs in acute myeloid leukemia.
Mol Cancer
; 20(1): 149, 2021 11 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34794438
3.
Liquid biopsy for therapy monitoring in early-stage non-small cell lung cancer.
Mol Cancer
; 20(1): 82, 2021 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34074295
4.
Sequencing of novel agents in relapsed/refractory B-cell acute lymphoblastic leukemia: Blinatumomab and inotuzumab ozogamicin may have comparable efficacy as first or second novel agent therapy in relapsed/refractory acute lymphoblastic leukemia.
Cancer
; 127(7): 1039-1048, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33259056
5.
Rational management approach to pure red cell aplasia.
Haematologica
; 103(2): 221-230, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29217782
6.
Longitudinal experience with WHO Grade III (anaplastic) meningiomas at a single institution.
J Neurooncol
; 131(3): 555-563, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27864703
7.
The crossroads of cancer therapies and clonal hematopoiesis.
Semin Hematol
; 61(1): 16-21, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38403501
8.
Manifestation of Pancytopenia Associated with COVID-19 as Paroxysmal Nocturnal Hemoglobinuria (PNH) and Aplastic Anemia (AA).
Hematol Rep
; 16(1): 42-49, 2024 Jan 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38247995
9.
The evolution of paroxysmal nocturnal haemoglobinuria depends on intensity of immunosuppressive therapy.
Br J Haematol
; 182(5): 730-733, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28804905
10.
Therapeutic outcomes using subcutaneous low dose alemtuzumab for acquired bone marrow failure conditions.
Br J Haematol
; 183(1): 133-136, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28905372
11.
Inflammation of actinic keratosis from chemotherapy in a relapsed multiple myeloma patient.
BMJ Case Rep
; 16(11)2023 Nov 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37989327
12.
Efficacy analysis of different FLT3 inhibitors in patients with relapsed/refractory acute myeloid leukemia and high-risk myelodysplastic syndrome.
EJHaem
; 4(1): 165-173, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36819163
13.
Novel scheme for defining the clinical implications of TP53 mutations in myeloid neoplasia.
J Hematol Oncol
; 16(1): 91, 2023 08 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37537667
14.
Novel Scheme for Defining the Clinical Implications of TP53 Mutations in Myeloid Neoplasia.
Res Sq
; 2023 Mar 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36945617
15.
Molecular patterns identify distinct subclasses of myeloid neoplasia.
Nat Commun
; 14(1): 3136, 2023 05 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37253784
16.
Selective inhibition of nuclear export: a promising approach in the shifting treatment paradigms for hematological neoplasms.
Leukemia
; 36(3): 601-612, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35091658
17.
Late Presentation of Dyskeratosis Congenita: Germline Predisposition to Adult-Onset Secondary Acute Myeloid Leukemia.
Hematol Rep
; 14(4): 294-299, 2022 Oct 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36278519
18.
PAK4 and NAMPT as Novel Therapeutic Targets in Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, and Mantle Cell Lymphoma.
Cancers (Basel)
; 14(1)2021 Dec 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-35008323
19.
Multi-institutional study evaluating clinical outcome with allogeneic hematopoietic stem cell transplantation after blinatumomab in patients with B-cell acute lymphoblastic leukemia: real-world data.
Bone Marrow Transplant
; 56(8): 1998-2004, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33824440
20.
Impact of EGFR mutation and ALK rearrangement on the outcomes of non-small cell lung cancer patients with brain metastasis.
Neuro Oncol
; 22(2): 267-277, 2020 02 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-31648302